Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 12:12:1513888.
doi: 10.3389/fmed.2025.1513888. eCollection 2025.

Efficacy of acupuncture as adjunctive therapy for patients with acute exacerbation of chronic obstructive pulmonary disease: a systematic review and meta-analysis

Affiliations

Efficacy of acupuncture as adjunctive therapy for patients with acute exacerbation of chronic obstructive pulmonary disease: a systematic review and meta-analysis

Guofeng Li et al. Front Med (Lausanne). .

Abstract

Background: Chronic obstructive pulmonary disease (COPD) is a highly prevalent and potentially fatal respiratory condition. Acute exacerbations can accelerate lung function decline and increase mortality. Acupuncture has been increasingly used as an adjunctive treatment for respiratory diseases, but its effectiveness in acute exacerbations of COPD (AECOPD) remains controversial. Existing evaluations on this topic are limited in scope and depth. This study aimed to provide a more comprehensive review to evaluate the effectiveness of acupuncture as an adjuvant treatment for acute exacerbations of chronic obstructive pulmonary disease.

Study design: Systematic review and meta-analysis of existing randomized controlled trials on acupuncture-assisted treatment of acute exacerbation of chronic obstructive pulmonary disease (AECOPD).

Methods: We included randomized controlled trials (RCTs) comparing acupuncture combined with conventional Western medicine to conventional Western medicine alone in patients with acute exacerbations of COPD (AECOPD). Our literature search covered ten databases, including PubMed and Web of Science ect., up until March 2025. The primary outcome was the effective rate, while secondary outcomes included lung function (FEV1%, FEV1/FVC%, FEV1), arterial blood gas analysis (PaO2, PaCO2, SaO2), the 6-min walk test (6MWT), COPD Assessment Test (CAT), modified Medical Research Council (mMRC) scale, and success rate of weaning. Data were extracted from eligible studies, and statistical analysis was performed using RevMan 5.3 and Stata 16.0. Risk of bias and evidence quality were assessed using Cochrane tools and GRADE methodology.

Results: The study included 31 randomized controlled trials (RCTs) with 2,299 participants. The studies were primarily conducted in hospital inpatient departments, and the typical treatment duration ranged from 1 to 2 weeks. Compared with conventional Western medicine alone, acupuncture combined with conventional Western medicine showed greater effectiveness (RR = 1.23, 95%CI 1.17 ~ 1.29, p < 0.001). Acupuncture significantly improved lung function (FEV1%: MD = 5.67, 95%CI 2.97 ~ 8.37, p < 0.001; FEV1/FVC: MD = 4.44, 95%CI 1.86 ~ 7.03, p < 0.001; FEV1: MD = 0.37, 95%CI 0.26 ~ 0.47, p < 0.001), reduced hypoxia (PaO2: MD = 3.60, 95%CI 2.23 ~ 4.98, p < 0.001; PaCO2: MD = -3.30, 95%CI -5.80 ~ -0.80, p < 0.05; SaO2: MD = 4.23, 95%CI 3.02 ~ 5.43, p < 0.001), and improved exercise tolerance (6MWT: MD = 40.34, 95%CI 30.50 ~ 50.17, p < 0.001), quality of life (CAT: MD = -2.68, 95%CI -3.39 ~ -1.96, p < 0.001), and dyspnea (mMRC: MD = -0.33, 95%CI -0.47 ~ -0.20, p < 0.001). However, the weaning success rate did not show a statistically significant difference between the two groups (RR = 1.18, 95%CI 0.95 ~ 1.48, p = 0.14). Mild side effects were reported in some studies. We rated the quality of evidence as very low to medium.

Conclusion: This systematic review and meta-analysis demonstrate that acupuncture, as an adjunctive treatment for acute exacerbations of chronic obstructive pulmonary disease, improves clinical efficacy and key outcomes. Our findings are consistent with previous studies that demonstrated improvements in the COPD Assessment Test (CAT) and arterial blood gas parameters (PaO2 and PaCO2). Unlike previous meta-analyses, the present study showed that adjunctive acupuncture significantly improved patient lung function FEV1% outcomes and significantly improved patient 6-min walk distance and modified Medical Research Council (mMRC) score; however, there was no significant difference in the success rate of weaning between the two groups. Although the review highlights clinical benefits, the heterogeneity of the included studies and the overall quality of the evidence suggest that more high-quality randomized controlled trials are needed to validate these findings and optimize treatment strategies. These studies should also prioritize standardizing acupuncture regimens, extending treatment duration, and conducting long-term follow-up assessments.

Systematic review registration: https://www.crd.york.ac.uk/prospero/ ID:CRD42024528155.

Keywords: acupuncture; acute exacerbation of chronic obstructive pulmonary disease; efficacy; meta-analysis; systematic review.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Flow chart of literature screening.
Figure 2
Figure 2
Risk of bias analysis. (A) Risk of bias summary; (B) Literature risk assessment diagram.
Figure 3
Figure 3
Acupuncture plus routine treatment versus routine treatment with effective rate. (A): Forest plot of effective rate; (B): Forest plot of effective rate after removing Chen’s study; (C): Subgroup analysis of acupuncture modalities; (D): Funnel plot of effective rate; (E): Funnel plot of effective rate after applying trim and fill method.
Figure 4
Figure 4
Acupuncture plus routine treatment versus routine treatment with FEV1%. (A): Forest plot of FEV1%; (B): Subgroup analysis of FEV1% (point stimulation amount); (C): Subgroup analysis of FEV1% (point stimulation time); (D): Subgroup analysis of FEV1% (acupuncture manipulation); (E): Subgroup analysis of FEV1% (acupuncture modalities); (F): Funnel plot of FEV1%.
Figure 5
Figure 5
Acupuncture plus routine treatment versus routine treatment with FEV1/FVC. (A): Forest plot of FEV1/FVC; (B): Subgroup analysis of FEV1/FVC (point stimulation amount); (C): Subgroup analysis of FEV1/FVC (point stimulation time); (D): Subgroup analysis of FEV1/FVC (acupuncture manipulations); (E): Subgroup analysis of FEV1/FVC (acupuncture modalities); (F): Funnel plot of FEV1/FVC.
Figure 6
Figure 6
Acupuncture plus routine treatment versus routine treatment with FEV1. (A): Forest plot of FEV1; (B): Subgroup analysis of FEV1 (point stimulation amount); (C): Subgroup analysis of FEV1 (stimulation time); (D): Subgroup analysis of FEV1 (acupuncture manipulations); (E): Subgroup analysis of FEV1 (treatment duration); (F): Subgroup analysis of FEV1 (acupuncture modalities).
Figure 7
Figure 7
Acupuncture plus routine treatment versus routine treatment with blood gas analysis. (A): Forest plot of PaO2; (B): Forest plot of PaO2 after removing Yang’s study; (C): Forest plot of PaCO2; (D): Subgroup analysis of PaO2 (point stimulation amount); (E): Subgroup analysis of PaO2 (acupuncture manipulation); (F): Forest plot of SaCO2; (G): Forest plot of SaCO2 after removing Long’s study.
Figure 8
Figure 8
Acupuncture plus routine treatment versus routine treatment with sports endurance and quality of life. (A): Forest plot of 6MWT; (B): Forest plot of 6MWT after removing Zhan’s study (1); (C): Forest plot of CAT; (D): Forest plot of CAT after removing Xie’s study; (E): Forest plot of mMRC; (F): Subgroup analysis of mMRC (point stimulation amount); (G): Subgroup analysis of mMRC (acupuncture manipulation); (H): Subgroup analysis of mMRC (treatment duration); (I): Forest plot of success rate of weaning.

Similar articles

Cited by

References

    1. Global Initiative for Chronic Obstructive Lung Disease (GOLD) . Global strategy for prevention, diagnosis and management of chronic obstructive pulmonary disease: 2025 report. (2024). Available online at: http://www.goldcopd.org/2025-gold-report/ (accessed November 11, 2024).
    1. Shah CH, Onukwugha E, Zafari Z, Villalonga-Olives E, Park JE, Slejko JF. Economic burden of comorbidities among COPD patients hospitalized for acute exacerbations: an analysis of a commercially insured population. Expert Rev Pharmacoecon Outcomes Res. (2022) 22:683–90. doi: 10.1080/14737167.2021.1981291, PMID: - DOI - PubMed
    1. Halpin DMG, Decramer M, Celli BR, Mueller A, Metzdorf N, Tashkin DP. Effect of a single exacerbation on decline in lung function in Copd. Respir Med. (2017) 128:85–91. doi: 10.1016/j.rmed.2017.04.013, PMID: - DOI - PubMed
    1. Nordon C, Rhodes K, Quint JK, Vogelmeier CF, Simons SO, Hawkins NM, et al. . Exacerbations of Copd and their outcomes on cardiovascular diseases (Exacos-cv) Programme: protocol of multicountry observational cohort studies. BMJ Open. (2023) 13:e070022. doi: 10.1136/bmjopen-2022-070022, PMID: - DOI - PMC - PubMed
    1. Rothnie KJ, Müllerová H, Smeeth L, Quint JK. Natural history of chronic obstructive pulmonary disease exacerbations in a general practice-based population with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. (2018) 198:464–71. doi: 10.1164/rccm.201710-2029OC, PMID: - DOI - PMC - PubMed

Publication types

LinkOut - more resources